Literature DB >> 10779344

Binding of equine infectious anemia virus rev to an exon splicing enhancer mediates alternative splicing and nuclear export of viral mRNAs.

M Belshan1, G S Park, P Bilodeau, C M Stoltzfus, S Carpenter.   

Abstract

In addition to facilitating the nuclear export of incompletely spliced viral mRNAs, equine infectious anemia virus (EIAV) Rev regulates alternative splicing of the third exon of the tat/rev mRNA. In the presence of Rev, this exon of the bicistronic RNA is skipped in a fraction of the spliced mRNAs. In this report, the cis-acting requirements for exon 3 usage were correlated with sequences necessary for Rev binding and transport of incompletely spliced RNA. The presence of a purine-rich exon splicing enhancer (ESE) was required for exon 3 recognition, and the addition of Rev inhibited exon 3 splicing. Glutathione-S-transferase (GST)-Rev bound to probes containing the ESE, and mutation of GAA repeats to GCA within the ESE inhibited both exon 3 recognition in RNA splicing experiments and GST-Rev binding in vitro. These results suggest that Rev regulates alternative splicing by binding at or near the ESE to block SR protein-ESE interactions. A 57-nucleotide sequence containing the ESE was sufficient to mediate Rev-dependent nuclear export of incompletely spliced RNAs. Rev export activity was significantly inhibited by mutation of the ESE or by trans-complementation with SF2/ASF. These results indicate that the ESE functions as a Rev-responsive element and demonstrate that EIAV Rev mediates exon 3 exclusion through protein-RNA interactions required for efficient export of incompletely spliced viral RNAs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779344      PMCID: PMC85647          DOI: 10.1128/MCB.20.10.3550-3557.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA.

Authors:  A W Cochrane; C H Chen; C A Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

2.  Biological characterization of Rev variation in equine infectious anemia virus.

Authors:  M Belshan; M E Harris; A E Shoemaker; T J Hope; S Carpenter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Sequence-specific RNA binding by the HIV-1 Rev protein.

Authors:  M L Zapp; M R Green
Journal:  Nature       Date:  1989-12-07       Impact factor: 49.962

4.  Interactions among SR proteins, an exonic splicing enhancer, and a lentivirus Rev protein regulate alternative splicing.

Authors:  R R Gontarek; D Derse
Journal:  Mol Cell Biol       Date:  1996-05       Impact factor: 4.272

5.  Secondary structure is the major determinant for interaction of HIV rev protein with RNA.

Authors:  H S Olsen; P Nelbock; A W Cochrane; C A Rosen
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

Review 6.  The superfamily of arginine/serine-rich splicing factors.

Authors:  X D Fu
Journal:  RNA       Date:  1995-09       Impact factor: 4.942

7.  Nucleotide sequence analysis of equine infectious anemia virus proviral DNA.

Authors:  T Kawakami; L Sherman; J Dahlberg; A Gazit; A Yaniv; S R Tronick; S A Aaronson
Journal:  Virology       Date:  1987-06       Impact factor: 3.616

8.  HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.

Authors:  D M Powell; M C Amaral; J Y Wu; T Maniatis; W C Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

9.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

10.  Signals for ribosomal frameshifting in the Rous sarcoma virus gag-pol region.

Authors:  T Jacks; H D Madhani; F R Masiarz; H E Varmus
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

View more
  14 in total

1.  Subpopulations of equine infectious anemia virus Rev coexist in vivo and differ in phenotype.

Authors:  Prasith Baccam; Robert J Thompson; Yuxing Li; Wendy O Sparks; Michael Belshan; Karin S Dorman; Yvonne Wannemuehler; J Lindsay Oaks; James L Cornette; Susan Carpenter
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Characterization of functional domains of equine infectious anemia virus Rev suggests a bipartite RNA-binding domain.

Authors:  Jae-Hyung Lee; Sean C Murphy; Michael Belshan; Wendy O Sparks; Yvonne Wannemuehler; Sijun Liu; Thomas J Hope; Drena Dobbs; Susan Carpenter
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

3.  Selective inhibition of splicing at the avian sarcoma virus src 3' splice site by direct-repeat posttranscriptional cis elements.

Authors:  W Guo; S C Winistorfer; C M Stoltzfus
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Equine infectious anemia virus resists the antiretroviral activity of equine APOBEC3 proteins through a packaging-independent mechanism.

Authors:  Hal P Bogerd; Rebecca L Tallmadge; J Lindsay Oaks; Susan Carpenter; Bryan R Cullen
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

5.  Structural Mimicry Drives HIV-1 Rev-Mediated HERV-K Expression.

Authors:  Ina P O'Carroll; Lixin Fan; Tomáš Kroupa; Erin K McShane; Christophe Theodore; Elizabeth A Yates; Benjamin Kondrup; Jienyu Ding; Tyler S Martin; Alan Rein; Yun-Xing Wang
Journal:  J Mol Biol       Date:  2020-11-14       Impact factor: 5.469

6.  Mapping of the functional boundaries and secondary structure of the mouse mammary tumor virus Rem-responsive element.

Authors:  Jennifer A Mertz; Amanda B Chadee; Hyewon Byun; Rick Russell; Jaquelin P Dudley
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

7.  Development of an equine-tropic replication-competent lentivirus assay for equine infectious anemia virus-based lentiviral vectors.

Authors:  Daniel C Farley; Richard Bannister; Marie A Leroux-Carlucci; Nerys E Evans; James E Miskin; Kyriacos A Mitrophanous
Journal:  Hum Gene Ther Methods       Date:  2012-11-02       Impact factor: 2.396

Review 8.  Rev variation during persistent lentivirus infection.

Authors:  Susan Carpenter; Wei-Chen Chen; Karin S Dorman
Journal:  Viruses       Date:  2011-01-11       Impact factor: 5.818

Review 9.  The retrovirus RNA trafficking granule: from birth to maturity.

Authors:  Alan W Cochrane; Mark T McNally; Andrew J Mouland
Journal:  Retrovirology       Date:  2006-03-17       Impact factor: 4.602

10.  Structural model of the Rev regulatory protein from equine infectious anemia virus.

Authors:  Yungok Ihm; Wendy O Sparks; Jae-Hyung Lee; Haibo Cao; Susan Carpenter; Cai-Zhuang Wang; Kai-Ming Ho; Drena Dobbs
Journal:  PLoS One       Date:  2009-01-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.